Key result
IV diltiazem converts new-onset lone AF to sinus rhythm within 24 hours in pregnancy.
Why the study?
Lone atrial fibrillation in pregnancy is rare and requires exclusion of underlying cardiopulmonary and non-cardiac diseases, with limited published case reports.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
May support diltiazem consideration in select pregnant AF; hypothesis-generating case report requiring prospective validation.
Atrial fibrillation (AF) is one of the most common arrhythmias and is a rare phenomenon seen in pregnant patients unless there is an underlying cardiopulmonary abnormality. Lone AF in pregnancy is a diagnosis of exclusion. A thorough workup including history, physical examination, imaging, and laboratory workup should be done diligently to exclude cardiopulmonary diseases (like hypertensive heart disease, congenital heart disease, valvular heart disease, asthma or chronic obstructive pulmonary disease, pulmonary embolism, rheumatic heart disease) and non-cardiac diseases (such as hyperthyroidism or electrolyte abnormalities or medications). There are very few case reports and studies published so far on this topic. This case report is on a pregnant patient without any significant past medical history who developed new-onset lone AF without any known cause and was managed with Diltiazem, which resulted in chemical cardioversion of atrial fibrillation with rapid ventricular rate to normal sinus rhythm.
No takes yet. Share an insight, caveat, or question.
Sinha et al. (2023) conducted a case report in Lone atrial fibrillation (n=1). Diltiazem was evaluated on Cardioversion to normal sinus rhythm. Intravenous Diltiazem successfully achieved chemical cardioversion to normal sinus rhythm within 24 hours in a pregnant patient with new-onset lone atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: